Vancomycin IV Bags Recalled Due to Lack of Sterility Assurance
Central Admixture Pharmacy Services is recalling 2,914 bags of vancomycin IV medication nationwide due to lack of assurance of sterility caused by missing validation data for decontamination cycles.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of sterile injectable medication where validation data for sterilization is lacking. Though no illnesses or injuries have been reported, the potential for contamination in direct-injection products constitutes a risk-of-harm scenario.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling 2,914 bags of vancomycin 1.5 g/250mL added to 5% dextrose IV bags that were distributed nationwide. The affected lot numbers are: 36-239516 and 36-239517 (expiring 7/12/2023), 36-239989 (expiring 7/13/2023), 36-240798 (expiring 7/17/2023), 36-241133 (expiring 7/19/2023), 36-241981 (expiring 7/24/2023), 36-242717 (expiring 7/26/2023), and 36-245577 (expiring 8/2/2023).
The recall is due to lack of assurance of sterility. Validation data for decontamination cycles is lacking, which means the manufacturer cannot confirm that these IV bags have been properly sterilized and are safe for use.
Healthcare providers and patients who have received any of these products should contact Central Admixture Pharmacy Services or their healthcare provider. Any remaining stock of these products should not be used.
The recalled product
- Product
- vancomycin 1.5 g/250mL added to 5% dextrose, 6 mg/mL, IV Bag, Rx only, Cental Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-6075-1
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Category
- Drug — IV Admixture
- Hazard
- sterility-failure
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (15)
- Lot: 36-239516
- 36-239517
- Exp. 7/12/2023
- 36-239989
- Exp. 7/13/2023
- 36-240798
- Exp. 7/17/2023
- 36-241133
- Exp. 7/19/2023
- 36-241981
- Exp. 7/24/2023
- 36-242717
- Exp. 7/26/2023
- 36-245577
- Exp. 8/2/2023.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27